project id: TCGA-OV; case submitter id: TCGA-13-2061; selected normal wgs: true; state: released; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 0.8; rna integrity number: 6.8; spectrophotometer method: UV Spec; age at index: 58; days to birth: -21543; ethnicity: not hispanic or latino; gender: female; race: white; vital status: Alive; year of birth: 1951; age at diagnosis: 21543; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 2339.0; figo stage: Stage IIIC; icd 10 code: C56.9; last known disease status: not reported; morphology: 8441/3; primary diagnosis: Serous cystadenocarcinoma, NOS; prior malignancy: not reported; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Ovary; synchronous malignancy: Not Reported; tissue or organ of origin: Ovary; tumor grade: Not Reported; year of diagnosis: 2009; alcohol history: Not Reported; is ffpe: false; composition: Not Reported; intermediate dimension: 1.5; longest dimension: 1.9; preservation method: Unknown; shortest dimension: 0.5; sample id: 7377ab66-ae3f-489c-a093-3ee0d707e385; sample submitter id: TCGA-13-2061-01A; portion id: 10859a76-d538-4fc0-a122-5a79f7350e20; portion submitter id: TCGA-13-2061-01A-01; percent neutrophil infiltration: 0.0; percent normal cells: 0.0; percent stromal cells: 10.0; percent tumor nuclei: 75.0;